A biological specimen (also called a biospecimen) is a biological laboratory specimen held by a biorepository for research. Such a specimen would be taken by sampling so as to be representative of any other specimen taken from the source of the specimen. When biological specimens are stored, ideally they remain equivalent to freshly-collected specimens for the purposes of research.
Human biological specimens are stored in a type of biorepository called a biobank, and the science of preserving biological specimens is most active in the field of biobanking.
Setting broad standards for quality of biological specimens was initially an underdeveloped aspect of biobank growth. There is currently discussion on what standards should be in place and who should manage those standards. Since many organizations set their own standards and since biobanks are necessarily used by multiple organizations and typically are driven towards expansion, the harmonization of standard operating procedures for lab practices are a high priority. The procedures have to be evidence-based and will change with time as new research and technology becomes available.
Some progress for the creation of policy-making organizations include the National Cancer Institute's 2005 creation of the Office of Biobanking and Biospecimen Research (OBBR) and the annual Biospecimen Research Network Symposia. The International Society for Biological and Environmental Repositories, International Agency for Research on Cancer, Organisation for Economic Co-operation and Development, and the Australasian Biospecimen Network have also proposed policies and standards. In 2008 AFNOR, a French standardization organization, published the first biobank-specific quality standard. Aspects of ISO 9000 have been applied to biobanks.
Quality criteria for specimens depends on the study being considered and there is not a universal standard specimen type. DNA integrity is an important factor for studies which involve whole genome amplification. RNA integrity is critical for some studies and can be assessed by gel electrophoresis. Also biobanks, which do specimen storage, cannot take full responsibility for specimen integrity, because before they take custody of samples someone must collect and process them and effects such as RNA degradation are more likely to occur from delayed sample processing than inadequate storage.
|cheek tissue||DNA profiling||buccal swab||participants can collect themselves; can be collected by mail; so easy to collect that informed consent may be insufficiently addressed|
|whole blood||venipuncture||requires phlebotomist to collect|
|Dried blood spot||gives high quality DNA and RNA||Fingerstick||stores easily for years at room temperature|
|organ tissue||gives high quality DNA, RNA, Mitochondrial DNA, and source of disease||Biopsy||many uses shared with blood; also suitable for proteomic analysis; may be difficult to obtain|
|Plasma||limited DNA and RNA content||Blood plasma fractionation||requires phlebotomist to collect|
|Urine||marker for some diagnostic tests||Urination||non-invasive|
|Feces||marker for some diagnostic tests||Stool sample||non-invasive|
|Skin||Mostly used by forensic teams investigating criminal cases||in criminal cases, collected without consent of donor|
|Hair||Mostly used by forensic teams investigating criminal cases||Hair analysis||in criminal cases, collected without consent of donor|
Techniques associated with biobanksEdit
- Hewitt, R. E. (2011). "Biobanking: The foundation of personalized medicine". Current Opinion in Oncology. 23 (1): 112–119. doi:10.1097/CCO.0b013e32834161b8. PMID 21076300.
- Moore, H. M.; Compton, C. C.; Lim, M. D.; Vaught, J.; Christiansen, K. N.; Alper, J. (2009). "2009 Biospecimen Research Network Symposium: Advancing Cancer Research Through Biospecimen Science". Cancer Research. 69 (17): 6770–6772. doi:10.1158/0008-5472.CAN-09-1795. PMC 2782665. PMID 19706749.
- Yuille, M.; Illig, T.; Hveem, K.; Schmitz, G.; Hansen, J.; Neumaier, M.; Tybring, G.; Wichmann, E.; Ollier, B. (2010). "Laboratory Management of Samples in Biobanks: European Consensus Expert Group Report". Biopreservation and Biobanking. 8 (1): 65–9. doi:10.1089/bio.2010.8102. PMID 24836342.
- Guerin, J. S.; Murray, D. W.; McGrath, M. M.; Yuille, M. A.; McPartlin, J. M.; Doran, P. P. (2010). "Molecular Medicine Ireland Guidelines for Standardized Biobanking". Biopreservation and Biobanking. 8 (1): 3–63. doi:10.1089/bio.2010.8101. PMID 24836341.
- Barnes, M. G.; Grom, A. A.; Griffin, T. A.; Colbert, R. A.; Thompson, S. D. (2010). "Gene Expression Profiles from Peripheral Blood Mononuclear Cells Are Sensitive to Short Processing Delays". Biopreservation and Biobanking. 8 (3): 153–162. doi:10.1089/bio.2010.0009. PMC 3129811. PMID 21743826.
- Elliott, P.; Peakman, T. C.; Uk, B. (2008). "The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine". International Journal of Epidemiology. 37 (2): 234–244. doi:10.1093/ije/dym276. PMID 18381398.
- Biospecimen research database, a curated collection of articles about biospecimens
- Office of Biorepositories and Biospecimen Research
- Specimen Central biorepository list, A worldwide listing of active biobanks and biorepositories
- Biospecimen Research Network Symposia, a conference on biobank specimens
- Mayo Clinic on biobanking
- Short Public TV episode on museum Collections